Low-risk prostate cancer patients may have good clinical outcomes by avoiding immediate treatmentMarch 16th, 2009 - 4:32 pm ICT by ANI
Washington, March 16 (ANI): A new study suggests that opting not to receive immediate treatment may be safe for men newly diagnosed with prostate cancer, and who are at minimal risk of cancer progression, if they are closely monitored.
Dr. Scott Eggener, assistant professor of surgery at the University of Chicago Medical Center, says that the study addresses an important question as to when to actively treat versus when to observe and closely monitor.
Radiation therapy and surgery are effective treatments, but they can be associated with serious long-term side effects like incontinence and erectile dysfunction.
The new study has shown that two separate biopsies are needed to determine optimal selection of patients for active surveillance, also known as “watchful waiting”, when patients decide not to undergo immediate treatment.
Dr. Eggener notes that there are no widely-accepted recommendations on which patients are appropriate candidates for active surveillance or when to perform second or “restaging” biopsies.
He says that a restaging biopsy provides doctors with additional information regarding the cancer, and is the best way to ensure the short-term success of active surveillance.
“When or if to treat men with low-risk prostate cancer has always been a challenging question that faces patients and urologists,” the researcher says.
“Some men may be rushing into treatment that won”t necessarily benefit them, prevent problems, or prolong life. Close observation in certain patients may provide and maintain quality of life without increasing the chances of the cancer spreading,” he adds.
According to Dr. Eggener, it is important for patients to undergo a restaging biopsy following the initial diagnostic biopsy, before active surveillance is elected.
The study conducted between 1991 and 2007 involved 262 men from four hospitals in the U.S. and Canada.
Of that initial pool electing surveillance of their cancer, 43 patients eventually chose treatment or had evidence of cancer progression prompting recommendation of treatment by their physician.
Following delayed treatment, all but one were cured of their cancer.
The remaining 219 patients remained on active surveillance without evidence of metastases.
“Active surveillance with delayed treatment, if necessary, for select patients appears to be safe and associated with a low risk of metastatic spread,” the study concludes.
Unlike many past studies on active surveillance that used data before PSA tests were widely available, this multi-centre study is based on patients who were screened with the PSA blood test, a widely used cancer-screening tool that predicts a man’’s chances of having prostate cancer.
“Active surveillance is not a total disregard for patients with prostate cancer. Instead, it identifies men unlikely to be affected by their cancer and encourages frequent monitoring, and then starting therapy at a later appropriate time if needed. Cure rates appear to be identical when these men choose immediate treatment or delayed treatment when prompted by new information about their condition,” Eggener says.
The study has been published in the Journal of Urology. (ANI)
- New method detects aggressive prostate cancer - Aug 09, 2012
- PSA test more reliable in men taking prostate-shrinking drug - Dec 18, 2010
- Now, test to predict aggressiveness of prostate cancer - Apr 20, 2010
- New test accurately detects aggressive prostate cancer - Apr 07, 2011
- High level of testosterone may speed up prostate cancer - Jul 31, 2012
- Exercise improves survival in prostate cancer patients - Feb 02, 2012
- Simple test could save prostate cancer patients from surgery - Feb 09, 2011
- MRI can help locate prostate cancer recurrence at extremely low PSA levels - Apr 30, 2011
- 'Watchful waiting' often best strategy for low-risk prostate cancer - Jun 19, 2010
- Hidden prostate cancer tumours evade treatment: study - Oct 09, 2009
- Change in PSA level poor predictor of prostate cancer - Feb 25, 2011
- Prostate cancer treatment 'ups risk of colorectal cancer' - Nov 16, 2010
- New tool opens alternate door to prostate cancer diagnosis - Apr 03, 2011
- New ultrasound technology can accurately spot prostate cancer tumours - Dec 09, 2010
- Prostate cancer screening improves patients' quality of life - Oct 26, 2010
Tags: assistant professor, biopsies, cancer progression, chicago medical center, clinical outcomes, close observation, diagnostic biopsy, dr scott, incontinence, initial pool, minimal risk, optimal selection, prostate cancer, prostate cancer patients, quality of life, radiation therapy, researcher, study suggests that, term success, university of chicago